Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Überörtliche Gemeinschaftspraxis für Hämatologie und Onkologie (GEHO)

Research site

Germany Düesbergweg 128, 48153 Munster, Germany

  • Lung neoplasm malignant · Non-small cell lung cancer · Non-small cell lung cancer metastatic
  • Adult patients

About Specializations

Überörtliche Gemeinschaftspraxis für Hämatologie und Onkologie (GEHO) in Munster, Germany specialises in clinical trials of conditions such as Lung neoplasm malignant, Non-small cell lung cancer, Non-small cell lung cancer metastatic, Non-small cell lung cancer stage II, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, focusing on innovative treatments for advanced/metastatic non-small cell lung cancer (NSCLC). By integrating novel therapies with existing standards, the center aims to enhance patient outcomes and quality of life.

  • Advanced Lung Cancer Therapies
  • Combination Treatment Strategies
  • Immunotherapy Advancements

Through its cutting-edge research, the center contributes significantly to the development of new therapeutic approaches, offering hope to patients with challenging cancer diagnoses.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Düesbergweg 12848153 MunsterGermany
Open in maps ↗
Recruiting now
no trials
Conditions studied
7

More sites in MunsterGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Non-small cell lung cancer+5

Not recruiting

Study of sacituzumab govitecan and zimberelimab treatment before and after surgery for patients with resectable non-small cell lung cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Zimberelimab
  • Sponsor:AIO-Studien gGmbH

Non-small cell lung cancer metastatic

Not recruiting

Study of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Immutep
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.